T. Sugisaki et al., THE INFLUENCE OF ENDOCRINE FACTORS ON THE SERUM CONCENTRATIONS OF INSULIN-LIKE GROWTH FACTOR-I (IGF-I) AND IGF-BINDING PROTEINS, Journal of Endocrinology, 138(3), 1993, pp. 467-477
Serum insulin-like growth factor-I (IGF-I) levels in lit (isolated GH
deficiency), dw (panhypopituitarism), hyt (hypothyroidism) and cog (co
ngenital goiter) mutant mice were found to be significantly lower than
in control mice. In addition, liver and kidney IGF-I concentrations i
n mutants were also found to be significantly reduced compared with co
ntrols. These differences in IGF-I concentration were not observed in
pg (genetic IGF receptor or post-receptor defect?) mice. These results
indicated that serum IGF-I production is induced by thyroid hormones
as well as by GH. Western blot analysis of serum IGF-binding protein (
IGFBP) fractions revealed the following differences among the five mut
ants: the triplet of IGFBP-3 (42, 45 and 49 kDa) and IGFBP-4 (24 kDa)
levels were significantly reduced. IGFBP-2 (32 kDa) levels were also r
educed in the lit, hyt and cog mice, although the level in serum of dw
mice was found to be greatly elevated. No differences in serum IGFBP
levels were found in the pg mouse. Consequently, the ratio of IGFBP-3%
:IGFBP-2% (the percentage of IGFBP-3 fraction of total IGFBP (IGFBP-3%
) divided by that of IGFBP-2 (IGFBP-2%)) was decreased in GH-deficient
mice but increased ill hypothyroid mice, suggesting that IGFBP-3 and
IGFBP-2 production in the liver is induced by GH and thyroid hormones
respectively.